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ABSTRACT Pseudomonas mesoacidophila ATCC 31433 is a Gram-negative bacterium,
first isolated from Japanese soil samples, that produces the monobactam isosulfaze-
cin and the -lactam-potentiating bulgecins. To characterize the biosynthetic poten-
tial of P. mesoacidophila ATCC 31433, its complete genome was determined using
single-molecule real-time DNA sequence analysis. The 7.8-Mb genome comprised
four replicons, three chromosomal (each encoding rRNA) and one plasmid. Phyloge-
netic analysis demonstrated that P. mesoacidophila ATCC 31433 was misclassified at
the time of its deposition and is a member of the Burkholderia cepacia complex,
most closely related to Burkholderia ubonensis. The sequenced genome shows con-
siderable additional biosynthetic potential; known gene clusters for malleilactone,
ornibactin, isosulfazecin, alkylhydroxyquinoline, and pyrrolnitrin biosynthesis and
several uncharacterized biosynthetic gene clusters for polyketides, nonribosomal
peptides, and other metabolites were identified. Furthermore, P. mesoacidophila ATCC
31433 harbors many genes associated with environmental resilience and antibiotic resis-
tance and was resistant to a range of antibiotics and metal ions. In summary, this bioac-
tive strain should be designated B. cepacia complex strain ATCC 31433, pending further
detailed taxonomic characterization.
IMPORTANCE This work reports the complete genome sequence of Pseudomonas
mesoacidophila ATCC 31433, a known producer of bioactive compounds. Large num-
bers of both known and novel biosynthetic gene clusters were identified, indicating
that P. mesoacidophila ATCC 31433 is an untapped resource for discovery of novel
bioactive compounds. Phylogenetic analysis demonstrated that P. mesoacidophila
ATCC 31433 is in fact a member of the Burkholderia cepacia complex, most closely
related to the species Burkholderia ubonensis. Further investigation of the classifica-
tion and biosynthetic potential of P. mesoacidophila ATCC 31433 is warranted.
KEYWORDS genome, identification, antibiotic resistance, metal resistance,
antibacterial, biosynthesis, bulgecin
Pseudomonas mesoacidophila was isolated from Japanese soil samples in the late1970s (1). It is known to produce the sulfamate monobactam isosulfazecin (1) and
the bulgecins (2), a group of sulfated glycopeptides that inhibit lytic transglycosylases
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(3) and metallo--lactamases (4) and potentiate -lactam activity (2, 5). Pseudomonas
and other soil Gram-negative bacterial genera, such as Stenotrophomonas and Burk-
holderia, often show high levels of resistance to antibiotics (6). For example, Pseudomo-
nas aeruginosa is a common nosocomial pathogen with reduced susceptibility to a
range of antibiotics, due to low membrane permeability, chromosomal multidrug efflux
pumps, overexpressed -lactamases, and the acquisition of multidrug resistance plas-
mids (6, 7). Stenotrophomonas maltophilia is an emerging nosocomial pathogen (8), and
several Burkholderia species, even environmental isolates, are resistant to a wide range
of antibiotic classes (9). Species of both Pseudomonas and Burkholderia produce an
array of specialized bioactive metabolites (10, 11). Despite these findings, the full
biosynthetic potential and antibiotic susceptibility of P. mesoacidophila have not been
reported. Here, we report the complete genome sequence of P. mesoacidophila, and we
show that this species shares an antimicrobial-resistant phenotype characteristic of
Burkholderia and should be reclassified phylogenetically as a member of the Burkhold-
eria cepacia complex.
RESULTS
Genome sequencing and taxonomic placement of P. mesoacidophila ATCC 31433
within the Burkholderia genus. Previous studies showed P. mesoacidophila ATCC 31433
to be a producer of specialized bioactive metabolites (1, 2, 12). There is only one known
example of this species, with no nucleotide sequences reported. Amplification and
sequencing of 16S, recA, and gyrB genes indicated that these sequences were closely
related to those of Burkholderia species (data not shown) (13). To characterize this
isolate, we obtained a complete genome sequence using PacBio technology. The
sequence assembled into four contigs, with a total size of 7.84 MB. The sequences of
six multilocus sequence typing (MLST) loci from the genome were compared to those
of characterized Burkholderia species. P. mesoacidophila ATCC 31433 clustered most
closely with Burkholderia ubonensis within the Burkholderia cepacia complex (Fig. 1),
which confirms its misclassification.
The genome sequence of P. mesoacidophila ATCC 31433 was compared to that of B.
ubonensis MSMB1471 (GenBank accession numbers NZ_CP013462, NZ_CP013463,
NZ_CP013464, and NZ_CP013465) (Fig. 2). Both genomes were organized similarly in
three chromosomes, each encoding rRNA, and were largely syntenic. The B. ubonensis
MSMB1471 and P. mesoacidophila ATCC 31433 genomes shared an average nucleotide
identity (ANI) of 94.7%, which falls below the proposed species-level cutoff value of
FIG 1 Phylogeny of P. mesoacidophila ATCC 31433 within the genus Burkholderia. The analysis was based
on the sequences of six MLST alleles (trpB, recA, lepA, gyrB, gltB, and atpD). The PubMLST isolate
identification numbers are shown in parentheses after the species names.
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95% (14). These data suggest that P. mesoacidophila ATCC 31433, while clearly a
member of the B. cepacia complex and related to B. ubonensis, may yet be a novel
species within this taxonomic subgroup of Burkholderia.
General features of the P. mesoacidophila ATCC 31433 genome. Annotation of
the genome revealed numerous elements that suggest resilience to environmental
conditions. Genes are present encoding detoxification proteins, such as nitric oxide
dioxygenase (flavohemoglobin), superoxide dismutase, catalase, catalase/peroxidase,
thiol peroxidase, alkylhydroperoxidase, alkylhydroperoxide reductase, alkylsulfonate
monooxygenase, and transport proteins, and a range of proteins involved in sulfite
metabolism, DNA repair, and the osmotic stress response. Genes and gene clusters
required for uptake and metabolism of chitin, collagen, pectin, phenylpropanoids,
phospholipids, glycerol, arabinose, ribose, fucose, xylose, trehalose, polyols, glycolate,
lactate, 2-ketogluconate, hydantoin, allantoin, heme, taurine, putrescine, and methyl-
amine were all identified. Siderophore synthetases, transport proteins, and receptors
are present, along with several other proteins involved in metal homeostasis. Genes
encoding a wide range of antibiotic resistance proteins and efflux pumps are also
present.
Interactions with the environment are also mediated by the chaperone-usher
fimbriae, Flp pili, type IV pili, adhesins, and biofilm-forming proteins (PgaABCD and
PelABCDEFG) identified, while motility is suggested by genes encoding flagellar com-
ponents. Lipopolysaccharide biosynthesis genes include those for O-antigen biosyn-
thesis and lipid A modification. A number of genes and gene clusters involved in
specialized metabolite biosynthesis were indicated. In addition, the genome contains
several phage proteins, transposases, and Tra and Trb conjugative transfer proteins.
P. mesoacidophila harbors genes encoding secreted enzymes and toxins involved
in virulence and interactions with hosts, such as phospholipases (including a
phosphatidylinositol-specific phospholipase C seen in other Burkholderia species [15]),
secreted collagenase, LasA protease, secreted zinc metalloprotease, pectin-degrading
polygalacturonase, HigAB, RelBE, YgiTU, and VapBC antitoxin-toxin pairs, RTX toxin, Phd
FIG 2 Genome sequence comparison of P. mesoacidophila ATCC 31433 and B. ubonensis MSMB1471. Each
chromosome (Chr) is displayed separately and to scale (as indicated), with P. mesoacidophila ATCC 31433 above
and B. ubonensis MSMB1471 below. Regions of homologous sequences are linked with red lines. AntiSMASH-
predicted gene clusters are shown in purple. The smallest contig of the P. mesoacidophila ATCC 31433 genome is
not shown, because it neither had homology with B. ubonensisMSMB1471 nor contained any antiSMASH-predicted
biosynthetic pathways.
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antitoxin, and toxin secretion proteins. Components of possible type I, II, III, IV, and VI
secretion systems have also been identified.
Specialized metabolite production by P. mesoacidophila ATCC 31433. To un-
cover the secondary metabolite potential of P. mesoacidophila, we analyzed the ge-
nome using the antiSMASH tool (16) and performed comparative investigations with
other B. ubonensis genomes. This identified 91 putative biosynthetic gene clusters from
five isolates. P. mesoacidophila yielded 24 clusters, suggesting 40% more biosynthetic
potential than the other B. ubonensis isolates analyzed (Table 1).
A small proportion of the biosynthetic clusters identified are required for the biosyn-
thesis of known compounds. Of the nine polyketide synthase (PKS) and nonribosomal
peptide synthetase (NRPS) clusters, three are known, three have equivalents in other
Burkholderia species, and three have no established equivalents indicated by antiSMASH.
The complete PKS cluster for malleilactone production (17) and the NRPS cluster for
ornibactin biosynthesis (18) were found, and the NRPS part of the ectoine-arylpolyene-
NRPS cluster is similar to the sulfazecin biosynthesis cluster in Pseudomonas acidophila (19),
with the exception that the SulM equivalent in P. mesoacidophila has no epimerization
domain. Therefore, this group of genes is likely to be responsible for isosulfazecin biosyn-
thesis. The complete four-gene cluster required for biosynthesis of the antifungal pyrrol-
nitrin (20) is present, although we could not detect production of this metabolite in either
culture broth or partially purified cell extracts with liquid chromatography-mass spectrom-
etry (LC-MS). Genes necessary for the synthesis of alkylhydroxyquinolines, which are
involved in quorum sensing (21), were found in one of the NRPS clusters.
One of the three terpene clusters constitutes part of the hopanoid biosynthetic
pathway described for Burkholderia cenocepacia J2315 (encoding seven proteins with
75% identity to their counterparts HpnCEFGMN and VacJ, plus two proteins not
found in that species) (15, 22). A response regulator gene just downstream of the
hpnCEFGMN cluster encodes a protein 84% identical to Bp1026b_II2523 from Burkhold-
eria pseudomallei, which is involved in thermoregulation and biofilm formation (23).
Clusters equivalent (75% identical at the protein level) to hpnABH/ispH and hpnIJKL/
ompA in B. cenocepacia J2315 (22) were also found, making up the entire hopanoid
biosynthetic pathway. The other two terpene clusters and the homoserine lactone-
terpene cluster contain one isolated squalene-hopene cyclase gene and two isolated
squalene synthase genes. The homoserine lactone synthase and its associated regulator
found in the homoserine lactone-terpene cluster, which are involved in quorum
sensing, encode proteins 85% identical to their equivalents in B. cenocepacia J2315
(15, 24).
In addition to core genes encoding fatty acid synthase components 80% identical
to those seen in other Burkholderia species (25), two genes encoding cyclopropane fatty
acyl phospholipid synthases (known components of Burkholderia cell membranes [26])
and one encoding diffusible factor synthase (90% identical at the protein level to
BCAM0581 from B. cenocepacia J2315), which is responsible for production of a fatty
acid involved in quorum sensing (27), were found. P. mesoacidophila also produces
poly(-hydroxybutanoate) (1), and poly(-hydroxyalkanoate) synthase and depoly-
merase genes were identified.
Production of bulgecin by P. mesoacidophila.We sought to confirm the presence
of bulgecin in the culture broth of P. mesoacidophila ATCC 31433. Bulgecin was shown
previously to potentiate the activity of -lactam antibiotics and to cause bulge forma-
tion in Escherichia coli (2, 28). After 78 h of growth at 28°C in PF medium, P. mesoaci-
dophila gave 36 g of cell pellet per liter of culture and reduced the pH of the medium
from 7.0 to 5.5  0.5. The medium acquired a distinctive fruity smell and remained
translucent even after repeated centrifugation at 6,000 g to remove cells. The culture
filtrate of P. mesoacidophila potentiated the lytic activity of cefuroxime against E. coli
and caused bulge formation (Fig. 3), as expected if bulgecin were present (2, 28). E. coli
JM109 cells exposed to a sublethal concentration of cefuroxime grew as long cell
chains, consistent with this compound’s selective inhibition of PBP3 and prevention of
Loveridge et al. Journal of Bacteriology
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proper septation (29), whereas cells exposed to the same concentration of cefuroxime
in P. mesoacidophila culture broth developed bulges at the sites of septation (2, 28).
Antibiotic and metal resistance of P. mesoacidophila. P. mesoacidophila was
resistant to a wide range of antibiotics (Table 2), including the antipseudomonal
aminoglycoside tobramycin, the carbapenems, the monobactam aztreonam, and poly-
myxin B. Of the 24 antibiotics tested, only the antipseudomonal -lactams piperacillin
and ceftazidime showed clear activity against P. mesoacidophila, with the fluoroquin-
olone ciprofloxacin and the fourth-generation cephalosporin cefepime showing inter-
mediate activity. In a few cases, the zone diameters in disc diffusion assays were close
to the breakpoint value (with some replicates indicating resistance and others suggest-
ing a degree of susceptibility), while the broth microdilution method clearly indicated
resistance. Burkholderia species are known to give poor correlation between the two
methods (30). E. coli JM109, which was tested simultaneously, was susceptible to all
antibiotics assayed except erythromycin and nalidixic acid, as expected (data not
shown).
P. mesoacidophila has predicted genes for -lactamases from classes A and C, along
with other proteins containing -lactamase domains. Inducible -lactamase activity
was demonstrated using cefoxitin (Table 3), whereas no inducible -lactamase activity
and much greater susceptibility to cefoxitin were seen for E. coli JM109. Two of the
genes thought to encode class A -lactamases have 63% and 54% identity with the
FIG 3 Cefuroxime potentiation and bulge-forming activity. (a) Growth curves of E. coli JM109 in PS
medium without (light blue) and with (dark blue) 5 g ml1 cefuroxime and in P. mesoacidophila culture
filtrate without (orange) and with (red) 5 g ml1 cefuroxime. (b to e) Light microscopy of E. coli JM109
alone (b) and exposed to 5 g ml1 cefuroxime (c), P. mesoacidophila culture filtrate (d), and a
combination of 5 g ml1 cefuroxime and P. mesoacidophila culture filtrate (e). Cefuroxime potentiation
and bulge formation are consistent with the presence of bulgecin (2, 28).
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genes encoding the known inducible class A -lactamase from Burkholderia mallei and
B. pseudomallei (31).
Resistance to polymyxin B is rare among Gram-negative species, including pseu-
domonads, but is well known among Burkholderia species, in which the modification of
lipid A prevents antibiotic binding (32). Indeed, the Arn gene cluster, which is respon-
sible for the biosynthesis of 4-amino-4-deoxyarabinose and its incorporation into lipid
A (33, 34), has been identified. This outer membrane modification also confers de-
creased susceptibility to aminoglycosides, which, together with a predicted aminogly-
coside phosphotransferase (also seen in B. cenocepacia strain J2315 [15]) and several
membrane efflux pumps, accounts for the marked resistance to this class of antibiotics
(35, 36).
The genome also carries genes encoding CreBCD colicin resistance proteins, a
bleomycin (glycopeptide) resistance protein (63% identical to the Tn5-mediated bleo-
mycin resistance protein [37], including conservation of the bleomycin-binding re-
gions), phosphinothricin N-acetyltransferase (36% identical to phosphinothricin N-
acetyltransferase from Brucella ovis [GenBank accession number WP_006155257; PDB
accession number 5DWN], with significant conservation of the active site), various
acyltransferases and glycosyltransferases that may play roles in resistance, and an
undecaprenyl diphosphatase associated with bacitracin resistance (38). Genes poten-
TABLE 2 Antibiotic susceptibility of P. mesoacidophila ATCC 31433, determined by the broth microdilution and disc diffusion methods
Antibiotic
Microdilution method Disc diffusion method
ResistanceMICa (g ml1)
Breakpointb
Dose (g)
Zone of
inhibition (mm)
Breakpointb
R (>) S (<) R (<) S (>)
Amoxicillin 128 (8) (8) 30 0 (14) (15) R
Co-amoxiclav 128 (8) (8) 20/10 0 (20) (21) R
Ampicillin ND 25 0 (14) (15) R
Carbenicillin 128 100 12 12 13 R
Piperacillin 8 16 16 75 37 24 25 S
Cefuroxime 128 (8) (8) 30 21 (19) (20) R
Cefoxitin 128 (8) (8) 30 8 (22) (23) R
Cefotaxime 16 (2) (1) 30 23 26 27 R
Ceftazidime 8 8 8 30 29 23 24 S
Cefepime 4 (4) (1) 30 31 (26) (30) I
Imipenem ND 8 4 10 12 16 23 R
Meropenem 16 8 2 10 19 15 20 R
Aztreonam 128 16 1 30 18 19 36 R
Erythromycin 128 30 0 R
Tetracycline 64 10 0 (23) (24) R
Chloramphenicol 32 (8) (8) 30 17 (20) (21) R
Streptomycin ND 10 0 R
Kanamycin 64 30 18 R
Gentamicin 128 4 4 10 9 17 18 R
Tobramycin ND 4 4 10 11 19 20 R
Nalidixic acid 32 (16) (16) 30 20 (17) (18) R
Ciprofloxacin 0.5 1 0.5 5 26 19 30 I
Rifampin 16 30 18
Polymyxin B 64 4 4 25 14 R
aND, not determined.
bBreakpoints are for Pseudomonas spp.; breakpoints in parentheses are for Enterobacteriaceae. The polymyxin B breakpoint is for colistin (polymyxin E). R, resistant;
I, intermediate; S, susceptible.
TABLE 3 Induction of -lactamase activity in P. mesoacidophila ATCC 31433 by cefoxitin
Cefoxitin concentration
(g ml1)a
Nitrocefin hydrolysis rate
(nM s1) Fold induction
0 22.7 3.4 1
1 28.7 1.4 1.3 0.2
10 68.5 1.2 3.0 0.5
100 300.8 29.9 13.2 2.4
aThe growth of P. mesoacidophila ATCC 31433 was unaffected by cefoxitin at the concentrations used.
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tially encoding putative trimethoprim-resistant dihydrofolate reductase FolM (25%
identity with FolM from E. coli) and chloramphenicol phosphotransferase (27% identical
to the N-terminal two-thirds of chloramphenicol phosphotransferase from Streptomyces
venezuelae [GenBank accession number CCA57350 {39}; PDB accession number 5DWN],
with the active site substantially conserved) were also found.
Genes encoding efflux pumps from the major facilitator superfamily (MFS); the
ATP-binding cassette (ABC) family, including a putative MacAB (macrolide resistance)
system; the resistance-nodulation-division (RND) family, including putative AcrAB (ac-
riflavin resistance), CmeABC, and NodT family pumps; the drug/metabolite transporter
(DMT) family, including putative EmrE (ethidium bromide/methyl viologen resistance)
proteins; the LysE family; and the multiantimicrobial extrusion (MATE) family were
identified. Efflux pumps specifically annotated as bicyclomycin (peptide) resistance and
fosmidomycin (phosphonate) resistance proteins are present.
P. mesoacidophila was also resistant to metal ions (Table 4), with the order of
resistance for the transition metals tested being as follows: Mn2  Ni2  Zn2 
Fe3  Cu2  Co2  Hg2. E. coli JM109, in comparison, was sensitive to all
transition metals tested, with MICs for MnCl2 and HgCl2 of 4 M. Several predicted
genes encoding heavy metal resistance proteins were found; these included arsenate
reductase and other arsenic resistance proteins, the chromate transporter ChrAB, the
cobalt/zinc/cadmium transporter CzcABCD (with a two-component regulator similar to
that mediating metal resistance in B. pseudomallei [40]), the copper resistance proteins
CopC and CopD, the HoxN/HupN/NixA family nickel/cobalt transporter, a lead/cadmi-
um/zinc/mercury transporter, the manganese transport protein MntH, the magnesium/
cobalt efflux pump CorAC, and the tellurium resistance proteins TerA, TerB, TerC, and
TerD.
DISCUSSION
The 7.8-MB genome of strain ATCC 31433 was sequenced and found to comprise
three chromosomal replicons and one plasmid. MLST analysis revealed that strain ATCC
31433, rather than being a pseudomonad, is a member of the Burkholderia cepacia
complex and is closely related to B. ubonensis, although it may still be a distinct species.
Further analysis of the bioactivity, taxonomy, and genomics of strain ATCC 31433 is
warranted under its reclassification as a member of the B. cepacia complex.
Strain ATCC 31433 harbors many genes associated with environmental resilience
and antibiotic resistance, including a wide range of efflux pumps. Antibiotic and metal
susceptibility testing confirmed the resistant phenotype. Only 2 of the 24 antibiotics
tested (piperacillin and ceftazidime) showed clear activity against strain ATCC 31433,
and similar resistance to transition metal ions was observed. While many of the
predicted heavy metal resistance genes encode efflux pumps, other detoxification
systems were also seen. Several environmental Burkholderia strains have been de-
scribed as metal resistant, although most of those strains are actually less tolerant of
TABLE 4Metal ion susceptibility of P. mesoacidophila ATCC 31433, as determined by the
broth microdilution method
Salta MIC (mg ml1) MIC (mM)
NaCl 15 257
KCl 10 133
MgCl2 10 105
CaCl2 10 90
MnCl2·4H2O 5 25
FeCl3 1 6
CoCl2·6H2O 0.25 1
NiCl2 1.25 10
CuCl2·2H2O 1 6
ZnCl2 1 7
HgCl2 0.008 0.03
aAll broths contained 5 mg ml1 NaCl.
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metal ions than P. mesoacidophila (40–43). The antibiotic resistance found in strain
ATCC 31433 is similar to that seen in Burkholderia species. Indeed, several Burkholderia
species with high-level -lactam resistance have been identified (9, 44). Pseudomonads
are generally susceptible to monobactams, carbapenems, cefepime, aminoglycosides,
and polymyxin B, whereas strain ATCC 31433 is resistant to all of these compounds,
including the antipseudomonal aminoglycoside tobramycin. Resistance to monobac-
tams may also be explained by the production of isosulfazecin by strain ATCC 31433 (1).
The biosynthetic gene cluster for this metabolite, like that for sulfazecin in P. acidophila
(19), contains efflux pumps and a -lactamase as self-resistance mechanisms.
Despite the potential pathogenicity suggested by the genome sequence, to our
knowledge there are no reported cases of strain ATCC 31433 causing disease; however,
opportunistic pathogenicity toward vulnerable hosts remains an inherent trait of the B.
cepacia complex (9). Conversely, the large number of biosynthetic gene clusters
identified in the genome of strain ATCC 31433 suggests that it may be a rich source of
specialized metabolites, compared to related Burkholderia species, and B. ubonensis has
been shown to have activity against the pathogen B. pseudomallei (45). AntiSMASH (16)
analysis of the strain ATCC 31433 genome identified known gene clusters for mallei-
lactone, ornibactin, isosulfazecin, alkylhydroxyquinoline, and pyrrolnitrin biosynthesis,
while revealing additional biosynthetic potential from uncharacterized biosynthetic
gene clusters for polyketides, nonribosomal peptides, and other metabolites. Genes
encoding bacteriocins, which are thought to represent the active principle in B.
ubonensis activity against B. pseudomallei (45), were found. The biosynthesis of bulgecin
is of particular interest. The biosynthetic route to the bulgecinine (4-hydroxy-5-
hydroxymethylproline) core of bulgecin (12, 46) is not known but may involve direct
elaboration of proline or the action of a transketolase on hydroxypyruvate and aspar-
tate semialdehyde, prior to transfer to NRPS, glycosyltransferase, and sulfotransferase
components for formation of bulgecin A itself. Several candidate genes have been
identified for further investigation.
In summary, the genome sequence of strain ATCC 31433 is consistent with that of
an environmental Burkholderia isolate from the B. cepacia complex. The full biosynthetic
potential of this strain, including determination of the location of the gene cluster
responsible for biosynthesis of the bulgecins and identification of the products of the
uncharacterized gene clusters, as well as precise classification of the strain, merits
further investigation. Bulgecin may prove to be a valuable tool for studying and
overcoming antibiotic resistance.
MATERIALS AND METHODS
Bacterial strains and susceptibility testing. P. mesoacidophila ATCC 31433 was purchased from
LGC Standards and was grown at 28°C in PS broth (1% [wt/vol] glucose, 0.5% [wt/vol] tryptone, 0.5%
[wt/vol] meat extract, 0.5% [wt/vol] NaCl [pH 7.0]) except where indicated. Escherichia coli JM109 was
purchased from Promega and was grown at 37°C in LB medium except where indicated. Antibiotics and
metal salts were obtained from Sigma-Aldrich (Poole, United Kingdom) or Melford (Ipswich, United
Kingdom). All antibiotic susceptibility testing followed the methods described by the BSAC (47), except
that Mueller-Hinton II agar (Sigma-Aldrich) was used for disc diffusion assays and PS broth was used for
broth microdilution assays. Breakpoints were taken from BSAC methods for antimicrobial susceptibility
testing version 14 (30). For disc diffusion assays, antibiotic discs (a maximum of 3 per plate) were
prepared using 5-mm filter paper discs impregnated with 5 l of antibiotic stock solution. Metal
susceptibility testing was performed only using broth microdilution assays, with 10, 1, or 0.001 mg ml1
metal salt as the highest concentration on the plate. Antibiotic and metal susceptibility testing was
performed at least in triplicate. Equivalent replicates for P. mesoacidophila and E. coli JM109 were
performed on the same day using the same antibiotic stock solution.
Genome analysis. Genomic DNA was prepared from a 3-ml overnight culture of P. mesoacidophila
in tryptic soy broth (Thermo Fisher Scientific). Cells were harvested by centrifugation and resuspended
in 400 l of 4 M guanidine isothiocyanate solution (Thermo Fisher Scientific). DNA extraction was
performed using the Maxwell 16 automated nucleic acid purification system with the Maxwell Tissue
DNA purification kit (Promega), following the manufacturer’s instructions.
The genome sequence was assembled from data obtained from two SMRT cells, with a PacBio RSII
sequencer, using Canu 1.3 (48), polished using Quiver 2.1.0 (Pacific Biosciences, Menlo Park, CA), and
circularized, where possible, using Circlator 1.2.1 (49). Gene annotations were made using PROKKA 1.11
(50) and RAST (51–53). Biosynthetic gene clusters in the genome were analyzed using AntiSMASH 3.0
(16). Graphical genome comparisons were obtained with EasyFig 2.2.2, and the ANI was calculated with
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pyani 0.2.1. A virtual machine hosted by the Cloud Infrastructure for Microbial Bioinformatics (CLIMB)
consortium (54) was used to perform genome assembly, annotation, and comparisons.
The sequences of six MLST alleles (trpB, recA, lepA, gyrB, gltB, and atpD) from P. mesoacidophila and
six available B. ubonensis genomes were concatenated and aligned. Publicly available complete B.
ubonensis genomes, deposited by Northern Arizona University, were downloaded from NCBI BioProject
accession number PRJNA279182. The corresponding loci from 26 Burkholderia species were downloaded
from the Burkholderia MLST database (http://pubMLST.org). A phylogeny was reconstructed with Ge-
neious 7.1.9 Tree Builder, using the Tamura-Nei genetic distance model and the neighbor-joining
tree-building method.
Detection of inducible -lactamase activity. Starter cultures of P. mesoacidophila and E. coli JM109
were each subcultured (1:50 dilution) into four 100-ml portions of fresh PS broth and were grown at 28°C.
Once A600 values of 	0.4 were attained, cefoxitin was added to give final concentrations of 0, 1, 10, and
100 g ml1. Three hours after the addition of cefoxitin, a 25-ml aliquot was removed from each flask
and the cells were lysed by sonication. The crude cellular lysate (100 l) was then added to 200 M
nitrocefin solution in 50 mM sodium cacodylate buffer (pH 7.0) containing 100 M ZnCl2 and 150 mM
NaCl (900 l), and the initial rate of hydrolysis was recorded by monitoring the decrease in absorbance
at 482 nm. Three repeats were obtained for each initial rate of hydrolysis, and the entire experiment was
performed in triplicate.
Detection of bulgecin activity. A 48-h culture of P. mesoacidophila in PS broth was subcultured (1:50
dilution) into PF broth (3% glycerol, 0.5% [wt/vol] tryptone, 0.5% [wt/vol] meat extract, 0.5% [wt/vol]
NaCl, 0.1% [wt/vol] glucose, 0.1% [wt/vol] cysteine [pH 7.0]) and incubated for 78 h at 28°C, at 200 rpm.
Cells were removed by centrifugation, and nutrients were replenished in the supernatant solution by the
addition of 0.8% (wt/vol) nutrient broth 3 (i.e., 0.5% [wt/vol] tryptone and 0.3% [wt/vol] meat extract)
(Sigma-Aldrich), 2% (wt/vol) glycerol, and 0.1% (wt/vol) glucose. All broths were readjusted to pH 7 and
held at 4°C overnight.
An overnight culture of E. coli JM109 in LB medium was subcultured (1:50 dilution) into fresh LB
medium and grown at 37°C to an A600 value of 	0.3, at 250 rpm. Cultures were centrifuged and the cell
pellets were resuspended in the test broths. Cultures were then grown for an additional 4 h at 37°C, at
250 rpm. Cefuroxime (final concentration, 5 g ml1) was added to one of each pair of flasks after 30 min;
60 and 90 min after cefuroxime addition, aliquots were removed and cells were viewed by light
microscopy using an Ultraphot microscope (Zeiss). These experiments were repeated four times.
Accession number(s). The assembled genome sequence has been deposited at GenBank under
accession numbers CP020737 to CP020740. The corresponding raw sequence read data are available
from the European Nucleotide Archive under accession number ERP022292.
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